News Focus
News Focus
icon url

KMBJN

07/28/20 11:39 PM

#315606 RE: KMBJN #315249

Top drug in that 12,000 drug screening study gets a Phase II study in Covid:

https://news.yale.edu/2020/07/27/yale-lead-trial-potential-covid-19-treatment

AI Therapeutics LAM022a apilimod.

I still wonder how brilacidin didn't make the cut.